Buch, Englisch, 370 Seiten, Paperback, Format (B × H): 121 mm x 171 mm
Buch, Englisch, 370 Seiten, Paperback, Format (B × H): 121 mm x 171 mm
ISBN: 978-1-61002-564-5
Verlag: AMER ACADEMY OF PEDIATRIC
For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.
TOPICS INCLUDE - Antimicrobial Therapy by Clinical Syndromes
- Antimicrobial Therapy for Neonates
- Choosing Among - Antibiotics
- Antifungal Agents
- Antiviral Agents
- Antiparasitic Agents
- Oral Step-down Therapy for Serious Infections
- Prevention of Symptomatic Infection
- Approach to Antibiotic Allergies
- Antibiotic Stewardship
New in the 28th Edition - Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
- Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022
- Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptible
- Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
- New dosing for posaconazole suspension formulation
- New approaches to mucormycosis
- Added baloxavir for children 12+ years old
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Pädiatrie, Neonatologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pflege Kinderkrankenpflege
Weitere Infos & Material
- Introduction
- Notable Changes to 2022 Nelson’s Pediatric Antimicrobial Therapy, 28th Edition
- 1. Antimicrobial Therapy According to Clinical Syndromes A. Skin and Soft Tissue Infections
- B. Skeletal Infections
- C. Eye Infections
- D. Ear and Sinus Infections
- E. Oropharyngeal Infections
- F. Lower Respiratory Tract Infections
- G. Cardiovascular Infections
- H. Gastrointestinal Infections
- I. Genital and Sexually Transmitted Infections
- J. Central Nervous System Infections
- K. Urinary Tract Infections
- L. Miscellaneous Systemic Infections
- 2. Antimicrobial Therapy for Neonates A. Recommended Therapy for Selected Neonatal Conditions
- B. Antimicrobial Dosages for Neonates
- C. Aminoglycosides
- D. Vancomycin
- E. Use of Antimicrobials During Pregnancy or Breastfeeding
- 3. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens A. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
- B. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
- C. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
- D. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
- 4. Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
- 5. Preferred Therapy for Specific Fungal Pathogens A. Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal SusceptibilitiesB. Systemic Infections
- C. Localized Mucocutaneous Infections
- 6. Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
- 7. Preferred Therapy for Specific Viral Pathogens A. Overview of Non-HIV, Non-hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
- B. Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
- C. Preferred Therapy for Specific Viral Pathogens
- 8. Choosing Among Antiviral Agents
- 9. Preferred Therapy for Specific Parasitic Pathogens A. Selected Common Pathogenic Parasites and Suggested Agents for Treatment.
- B. Preferred Therapy for Specific Parasitic Pathogens
- 10. Choosing Among Antiparasitic Agents: Antimalarial Drugs, Nitroimidazoles, Benzimidazoles, and Neglected Tropical Diseases
- 11. How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
- 12. Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus
- 13. Antibiotic Therapy for Children Who Are Obese
- 14. Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
- 15. Antimicrobial Prophylaxis/Prevention of Symptomatic Infection A. Postexposure Antimicrobial Prophylaxis to Prevent Infection
- B. Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
- C. Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
- D. Surgical/Procedure Prophylaxis
- 16. Approach to Antibiotic Allergies
- 17. Antibiotic Stewardship
- 18. Systemic and Topical Antimicrobial Dosing and Dose Forms A. Systemic Antimicrobials With Dosage Forms and Usual Dosages
- B. Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
- Appendix: Nomogram for Determining Body Surface Area
- References
- Index